All information on this website is intended strictly for educational and research purposes only.
The content on OpenPep — including peptide profiles, clinical trial summaries, dosing information, and reconstitution calculators — must not be used for:
OpenPep aggregates publicly available clinical trial data and research. We do not sell, distribute, or recommend any substances. All AI-generated summaries are interpretations of published research and may contain errors.
CJC-1295 with Drug Affinity Complex
For educational and research purposes only. Not medical advice.
CJC-1295 with DAC provides sustained GH elevation for 7-10 days per injection. Clinical studies showed significant IGF-1 increases. The long half-life means less frequent dosing but also 'GH bleed' (continuous low-level release) rather than natural pulsatile release.
Best Time
Evening
Method
subcutaneous
Frequency
1-2x per week
Half-life
~8 days
Cycle Length
8-12 weeks
Storage
Refrigerate at 2-8°C.
Published Dosing Ranges
Create an account to access peptide research data.
Contraindications
Create an account to access peptide research data.
Ipamorelin's clean GH pulse combined with DAC version's sustained release. Provides both acute spikes and elevated baseline. Requires careful dosing to avoid GH bleed.
communityOral GH secretagogue + injectable GHRH analog. Some use together but may cause excessive GH/IGF-1 elevation. Monitor blood glucose and IGF-1 levels.
communityDrug testing and analysis 13 (11-12) :1871-1887 · 2021-11-01
Mechanism of Action
GHRH analog with a Drug Affinity Complex (DAC) that binds to albumin in the bloodstream, extending its half-life dramatically. Provides sustained GH elevation over 7-10 days.
Reported by the community. These may not be supported by clinical evidence and are not medical recommendations.